Concentrix shares plunged 20% on July 7 after Levi & Korsinsky opened an investigation into the company's officers and directors over a massive revenue guidance revision.
"The company told investors to expect at least $10.035 billion in revenue for 2026, and now the ceiling is below the old floor," the law firm said in its investigation notice.
The guidance revision follows a disappointing second-quarter earnings report. Concentrix reported adjusted earnings of $2.63 per share on revenue of $2.46 billion, both narrowly missing analyst estimates. The company lowered its full-year 2026 adjusted EPS forecast to a range of $10.83 to $11.18, down from a prior range of $11.48 to $12.07. Third-quarter guidance of $2.65 to $2.77 per share also fell short of Wall Street expectations.
The investigation adds legal risk to a stock already under pressure. Concentrix has lost 39.1% year to date, and at $25.08 per share, it trades 59.5% below its 52-week high of $62 from July 2025. The probe will examine whether management made misleading statements about the company's financial outlook before the guidance revision.
The shareholder investigation puts Concentrix management on the defensive at a time when the company is trying to restore investor confidence. Investors will watch for potential class-action lawsuit filings and the next earnings call for clarity on the 2026 revenue trajectory.
This article is for informational purposes only and does not constitute investment advice.